Xiao Ling

 PhD student Profile
PhD student
Contact information

Exploring genomic instability to enhance anti-tumor immunity

 My research explores how genomic instability triggered by chemotherapy—such as paclitaxel—can reprogram the tumor microenvironment. I am particularly interested in how this stress activates inflammatory signaling through the cGAS–STING, NF-κB, and interferon pathways, ultimately engaging anti-tumor immunity and opening new directions for cancer treatment.
Dummy

Discover our research

publication

A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer

2025, Nature Communications
All publications